DCR-STAT3

DCR-STAT3 · Dicerna Pharmaceuticals, Inc. (a Novo Nordisk company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCR-STAT3, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DCR-STAT3 in Adults With Solid Tumors [Phase 1]